ATE276235T1 - Verfahren zur herstellung von thiocarbonsäuren - Google Patents

Verfahren zur herstellung von thiocarbonsäuren

Info

Publication number
ATE276235T1
ATE276235T1 AT01916231T AT01916231T ATE276235T1 AT E276235 T1 ATE276235 T1 AT E276235T1 AT 01916231 T AT01916231 T AT 01916231T AT 01916231 T AT01916231 T AT 01916231T AT E276235 T1 ATE276235 T1 AT E276235T1
Authority
AT
Austria
Prior art keywords
acids
thiocarboxic
producing
carbothiolates
androstane
Prior art date
Application number
AT01916231T
Other languages
German (de)
English (en)
Inventor
Jufang Barkalow
Steven A Chamberlin
Arthur J Cooper
Azad Hossain
John J Hufnagel
Denton C Langridge
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE276235T1 publication Critical patent/ATE276235T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/02Monothiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01916231T 2000-02-25 2001-02-23 Verfahren zur herstellung von thiocarbonsäuren ATE276235T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/513,399 US20020133032A1 (en) 2000-02-25 2000-02-25 Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
PCT/US2001/006055 WO2001062722A2 (en) 2000-02-25 2001-02-23 Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods

Publications (1)

Publication Number Publication Date
ATE276235T1 true ATE276235T1 (de) 2004-10-15

Family

ID=24043095

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01916231T ATE276235T1 (de) 2000-02-25 2001-02-23 Verfahren zur herstellung von thiocarbonsäuren

Country Status (11)

Country Link
US (2) US20020133032A1 (enExample)
EP (1) EP1257531B1 (enExample)
JP (1) JP3986313B2 (enExample)
AT (1) ATE276235T1 (enExample)
CA (1) CA2400919C (enExample)
DE (1) DE60105555T2 (enExample)
DK (1) DK1257531T3 (enExample)
ES (1) ES2228832T3 (enExample)
MX (1) MXPA02008275A (enExample)
PT (1) PT1257531E (enExample)
WO (1) WO2001062722A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0017988D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Novel process
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
SI1305329T2 (sl) 2000-08-05 2015-07-31 Glaxo Group Limited S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-(2-furanilkarboksil)oksi-11beta-hidroksi- 16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
CA2445839A1 (en) 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2002321884A1 (en) * 2001-08-03 2003-02-24 Smithkline Beecham Corporation A method for preparing fluticasone derivatives
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
AU2003263575A1 (en) 2002-06-20 2004-01-06 Sun Pharmaceutical Industries Limited Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate
IL153462A0 (en) * 2002-12-16 2003-07-06 Chemagis Ltd Thiocarboxylic acid organic salts and processes utilizing the same
EP1466920A1 (en) * 2003-04-04 2004-10-13 Alpharma APS Process for the preparation of steroidal 17 beta-carbothioates
CA2530680A1 (en) * 2003-04-04 2004-10-14 Alpharma Aps Process for the preparation of steroidal carbothioic acid derivatives and intermediates
EP1526139A1 (en) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters
PT103202B (pt) 2004-10-19 2011-01-27 Hovione Farmaciencia S A Processo para a esterificação de um ácido carbotiótico
CN100560598C (zh) * 2005-07-26 2009-11-18 上海奥锐特国际贸易有限公司 氟替卡松丙酸酯的合成方法
EP2402361B1 (en) * 2006-06-14 2020-04-15 Generics [UK] Limited Process for the preparation of s-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17-carbothioate and intermediates
US7265247B1 (en) 2006-07-28 2007-09-04 Im&T Research, Inc. Substituted phenylsulfur trifluoride and other like fluorinating agents
US8399720B2 (en) * 2007-03-23 2013-03-19 Ube Industries, Ltd. Methods for producing fluorinated phenylsulfur pentafluorides
RU2472779C2 (ru) * 2007-03-23 2013-01-20 УБЭ Индастриз, Лтд. Способ получения пентафторидов арилсеры
US8030516B2 (en) * 2007-10-19 2011-10-04 Ube Industries, Ltd. Methods for producing perfluoroalkanedi(sulfonyl chloride)
JP2011518765A (ja) * 2007-12-11 2011-06-30 宇部興産株式会社 ジフルオロメチレン−及びトリフルオロメチル−含有化合物を製造するための方法及び組成物
TW201006787A (en) * 2008-03-07 2010-02-16 Im & T Res Inc Fluorination processes with arylsulfur halotetrafluorides
WO2010022001A1 (en) * 2008-08-18 2010-02-25 Im&T Research, Inc. Methods for preparing fluoroalkyl arylsulfinyl compounds and fluorinated compounds thereto
KR101676054B1 (ko) * 2008-09-22 2016-11-14 우베 고산 가부시키가이샤 폴리(펜타플루오로설파닐)방향족 화합물을 제조하기 위한 공정
US20100174096A1 (en) * 2009-01-05 2010-07-08 Im&T Research, Inc. Methods for Production of Optically Active Fluoropyrrolidine Derivatives
WO2010081014A1 (en) 2009-01-09 2010-07-15 Im&T Research, Inc. Novel 4-fluoropyrrolidine-2-carbonyl fluoride compounds and their preparative methods
EP2611821A2 (en) 2010-09-01 2013-07-10 Cadila Healthcare Limited Process for preparing fluticasone propionate/furoate
CN102558273B (zh) * 2010-12-14 2014-07-02 浙江省天台县奥锐特药业有限公司 氟替卡松糠酸酯的制备方法
US9303060B1 (en) 2014-10-03 2016-04-05 Amphaster Pharmaceuticals, Inc. Methods of preparing intermediate of fluticasone propionate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
US4198403A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
GB2137206B (en) 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
CY1291A (en) 1980-02-15 1985-10-18 Glaxo Group Ltd Androstane 17 beta carbothioates
CA1201114A (en) * 1980-02-15 1986-02-25 Gordon H. Phillipps Androstane carbothioates
US4578221A (en) * 1980-04-23 1986-03-25 Glaxo Group Limited Androstane carbothioic acids
IL109656A (en) 1994-05-15 1998-02-22 Chemagis Ltd Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
GB9622173D0 (en) * 1996-10-24 1996-12-18 Glaxo Group Ltd Particulate Products
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
IL150654A (en) * 2002-07-09 2006-12-10 Ori Lerman Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate

Also Published As

Publication number Publication date
DE60105555T2 (de) 2005-09-29
DK1257531T3 (da) 2005-01-17
WO2001062722A3 (en) 2002-05-16
US20020133032A1 (en) 2002-09-19
JP3986313B2 (ja) 2007-10-03
PT1257531E (pt) 2005-01-31
JP2003529564A (ja) 2003-10-07
MXPA02008275A (es) 2003-01-28
EP1257531B1 (en) 2004-09-15
US7214807B2 (en) 2007-05-08
EP1257531A2 (en) 2002-11-20
DE60105555D1 (de) 2004-10-21
ES2228832T3 (es) 2005-04-16
US20040209854A1 (en) 2004-10-21
WO2001062722A2 (en) 2001-08-30
CA2400919C (en) 2009-01-20
CA2400919A1 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
ATE276235T1 (de) Verfahren zur herstellung von thiocarbonsäuren
DE60228118D1 (de) Verfahren zur herstellung von o-desmethylvenlafaxin
DE602005009856D1 (de) Verfahren zur reinigung von fsh
DE60125747D1 (de) Verfahren zur herstellung von 2-halobenzoesäuren
DE60227784D1 (de) Verfahren zur herstellung von alkenylphosphinoxiden oder alkenylphosphinsäureestern
AT7109U3 (de) Verfahren zur herstellung von amlodipinmaleat
DE60106933D1 (de) Verfahren zur herstellung von citalopram
DE60220074D1 (de) Verfahren zur Herstellung von Phosphorsäureestern
DE60018902D1 (de) Verfahren zur herstellung von nitroxymethylphenylestern von aspirinderivaten
DE50114998D1 (de) Verfahren zur herstellung von monolithischen chromatographiesäulen
DE60322852D1 (de) Verfahren zur herstellung von eplerenon
DE60026607D1 (de) Verfahren zur herstellung von perfluoroalkadienen
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
DE60120352D1 (de) Verfahren zur industriellen herstellung von betulinsäuren
DE60131954D1 (de) Verfahren zur herstellung von 2-hydroxy-4-methylthiobutansäure
DE60219188D1 (de) Verfahren zur herstellung von olefinen.
DE60133280D1 (de) Verfahren zur herstellung von citalopram
DE50104555D1 (de) Verfahren zur herstellung von tert.-butylestern aliphatischer c1-c4-carbonsäuren
EP1320367A4 (en) METHOD OF PREPARING DINAPSOLIN
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE60101277D1 (de) Verfahren zur Herstellung von Fluorenen
ATE267820T1 (de) Prozess zur herstellung von paclitaxel
DE60110478D1 (de) Verfahren zur Herstellung von Cyclododecanonverbindungen
DE60109786D1 (de) Verfahren zur herstellung von hydroxylactonen
ATE239695T1 (de) Stereoselektive verfahren zur herstellung von gabapentinanalogen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1257531

Country of ref document: EP